Bayan wani bala'i na rahoton na WHO, likitoci da kwararrun kiwon lafiya da yawa sun yi magana. Wannan shine lamarin Dr. Joil bousquet, likita a Cibiyar Tallafawa da Rigakafin Addictology a Gap wanda ke tunanin cewa " har yanzu ba mu da duk abin da ya dace don sanin sakamakon na dogon lokaci ".
"MUMMUNAR TASIRI HAR YANZU YANA WUYA A GANO"
A ranar 26 ga Yuli, l'World Health Organization (WHO) ta ƙara ƙararrawa a cikin Rahoton Taba ta Duniya ta kiran e-cigare "tabbas mai cutarwa".
« Tun da bayyanar sigari na lantarki a kasuwa, muna zargin cewa samfuran da aka shayar da su, ba tare da shakka ba, ba su da laifi kamar abin da za a iya sanar. Amma mun tabbata cewa wannan cutarwa ba ta da yawa idan aka kwatanta da sigari. Rashin guba na samfuran yana yiwuwa kuma har yanzu ya rage don tantancewa. Har yanzu ba mu da duk abin da ya wajaba don sanin sakamakon na dogon lokaci., girma Joel Bousquet ne adam wata, likita a Cibiyar Tallafi da Rigakafin Addictology a Gap.
Har yanzu yana da wuya a gano mummunan tasirin saboda binciken da masana suka yi ya bambanta. Amma taba sigari ya kasance madadin, da sauransu, don barin shan taba. Hakanan ana ɗaukarsa mafi inganci (ga sauran abubuwan maye gurbin nicotine: patch, lozenge, chewing gum, da sauransu) ta ƙungiyar masu binciken Burtaniya a cikin New England Journal of Medicine (an buga a Janairu 2019). Lokaci da bincike na gaba zai nuna. »
source : Ledauphine.com/
